These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24821064)

  • 41. Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival.
    Baenke F; Dubuis S; Brault C; Weigelt B; Dankworth B; Griffiths B; Jiang M; Mackay A; Saunders B; Spencer-Dene B; Ros S; Stamp G; Reis-Filho JS; Howell M; Zamboni N; Schulze A
    J Pathol; 2015 Oct; 237(2):152-65. PubMed ID: 25965974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MCT4 Expression Is a Potential Therapeutic Target in Colorectal Cancer with Peritoneal Carcinomatosis.
    Kim HK; Lee I; Bang H; Kim HC; Lee WY; Yun SH; Lee J; Lee SJ; Park YS; Kim KM; Kang WK
    Mol Cancer Ther; 2018 Apr; 17(4):838-848. PubMed ID: 29483215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: key events in the progression from an in situ to an invasive breast carcinoma.
    Martins D; Beça FF; Sousa B; Baltazar F; Paredes J; Schmitt F
    Cell Cycle; 2013 Aug; 12(16):2684-90. PubMed ID: 23907124
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts.
    Whitaker-Menezes D; Martinez-Outschoorn UE; Lin Z; Ertel A; Flomenberg N; Witkiewicz AK; Birbe RC; Howell A; Pavlides S; Gandara R; Pestell RG; Sotgia F; Philp NJ; Lisanti MP
    Cell Cycle; 2011 Jun; 10(11):1772-83. PubMed ID: 21558814
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decreased expression of p12 is associated with more advanced tumor invasion in human gastric cancer tissues.
    Choi MG; Sohn TS; Park SB; Paik YH; Noh JH; Kim KM; Park CK; Kim S
    Eur Surg Res; 2009; 42(4):223-9. PubMed ID: 19279387
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduced Krüppel-like factor 17 (KLF17) expression correlates with poor survival in patients with gastric cancer.
    Peng JJ; Wu B; Xiao XB; Shao YS; Feng Y; Yin MX
    Arch Med Res; 2014 Jul; 45(5):394-9. PubMed ID: 24947617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mitochondrial Metabolism as a Treatment Target in Anaplastic Thyroid Cancer.
    Johnson JM; Lai SY; Cotzia P; Cognetti D; Luginbuhl A; Pribitkin EA; Zhan T; Mollaee M; Domingo-Vidal M; Chen Y; Campling B; Bar-Ad V; Birbe R; Tuluc M; Martinez Outschoorn U; Curry J
    Semin Oncol; 2015 Dec; 42(6):915-22. PubMed ID: 26615136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer.
    Hu H; Li C; Cai S; Zhu C; Tian Y; Zheng J; Hu J; Chen C; Liu W
    Hepatogastroenterology; 2014; 61(133):1478-82. PubMed ID: 25436328
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The net acid extruders NHE1, NBCn1 and MCT4 promote mammary tumor growth through distinct but overlapping mechanisms.
    Andersen AP; Samsøe-Petersen J; Oernbo EK; Boedtkjer E; Moreira JMA; Kveiborg M; Pedersen SF
    Int J Cancer; 2018 Jun; 142(12):2529-2542. PubMed ID: 29363134
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis.
    Bovenzi CD; Hamilton J; Tassone P; Johnson J; Cognetti DM; Luginbuhl A; Keane WM; Zhan T; Tuluc M; Bar-Ad V; Martinez-Outschoorn U; Curry JM
    Biomed Res Int; 2015; 2015():242437. PubMed ID: 26779534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FOXO4 and FOXD3 are predictive of prognosis in gastric carcinoma patients.
    Li J; Jiang Z; Han F; Liu S; Yuan X; Tong J
    Oncotarget; 2016 May; 7(18):25585-92. PubMed ID: 27027443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ectopic expression of B and T lymphocyte attenuator in gastric cancer: a potential independent prognostic factor in patients with gastric cancer.
    Feng XY; Wen XZ; Tan XJ; Hou JH; Ding Y; Wang KF; Dong J; Zhou ZW; Chen YB; Zhang XS
    Mol Med Rep; 2015 Jan; 11(1):658-64. PubMed ID: 25334051
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic significance of human tissue kallikrein-related peptidases 6 and 10 in gastric cancer.
    Kolin DL; Sy K; Rotondo F; Bassily MN; Kovacs K; Brezden-Masley C; Streutker CJ; Yousef GM
    Biol Chem; 2014 Sep; 395(9):1087-93. PubMed ID: 25153389
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pilot study demonstrating metabolic and anti-proliferative effects of in vivo anti-oxidant supplementation with N-Acetylcysteine in Breast Cancer.
    Monti D; Sotgia F; Whitaker-Menezes D; Tuluc M; Birbe R; Berger A; Lazar M; Cotzia P; Draganova-Tacheva R; Lin Z; Domingo-Vidal M; Newberg A; Lisanti MP; Martinez-Outschoorn U
    Semin Oncol; 2017 Jun; 44(3):226-232. PubMed ID: 29248134
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PTK7 as a novel marker for favorable gastric cancer patient survival.
    Lin Y; Zhang LH; Wang XH; Xing XF; Cheng XJ; Dong B; Hu Y; Du H; Li YA; Zhu YB; Ding N; Du YX; Li JY; Ji JF
    J Surg Oncol; 2012 Dec; 106(7):880-6. PubMed ID: 22585737
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The relationship between the expressions of tumor associated fibroblasts Cav-1 and MCT4 and the prognosis of papillary carcinoma of breast.
    Zhai Y; Chai L; Chen J
    Pak J Pharm Sci; 2017 Jan; 30(1 Suppl):263-272. PubMed ID: 28625953
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MCT4 defines a glycolytic subtype of pancreatic cancer with poor prognosis and unique metabolic dependencies.
    Baek G; Tse YF; Hu Z; Cox D; Buboltz N; McCue P; Yeo CJ; White MA; DeBerardinis RJ; Knudsen ES; Witkiewicz AK
    Cell Rep; 2014 Dec; 9(6):2233-49. PubMed ID: 25497091
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Programmed Death-1 Ligand-1 (PDL1) Expression Is Associated with the Prognosis of Patients with Stage II/III Gastric Cancer.
    Tamura T; Ohira M; Tanaka H; Muguruma K; Toyokawa T; Kubo N; Sakurai K; Amano R; Kimura K; Shibutani M; Maeda K; Hirakawa K
    Anticancer Res; 2015 Oct; 35(10):5369-76. PubMed ID: 26408698
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinico-pathological significance of exosome marker CD63 expression on cancer cells and stromal cells in gastric cancer.
    Miki Y; Yashiro M; Okuno T; Kuroda K; Togano S; Hirakawa K; Ohira M
    PLoS One; 2018; 13(9):e0202956. PubMed ID: 30222750
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunohistochemical expression and localization of cytokines/chemokines/growth factors in gastric cancer.
    Raja UM; Gopal G; Shirley S; Ramakrishnan AS; Rajkumar T
    Cytokine; 2017 Jan; 89():82-90. PubMed ID: 27793525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.